This guidance document provides detailed information recommended for manufacturers seeking marketing clearance of diagnostic ultrasound systems and transducers.
Guidance for Industry and FDA Staff - Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers
FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
Vaccine against HER2-positive breast cancer offers complete protection in lab
Researchers at Wayne State University have tested a breast cancer vaccine they say completely eliminated HER2-positive tumors in mice - even cancers resistant to current anti-HER2 therapy - without any toxicity.
PPI Therapy a Risk Factor for C. difficile Diarrhea in Hospitalized Patients
Gastric acid suppression by proton pump inhibitors (PPIs) is associated with an increased risk of Clostridium difficile-related diarrhea in hospitalized patients, results of a case-control study indicate.
Reuters Health Information
Cephalon Says Expanded Fentora Label Not Approved
Cephalon Inc said on Monday that U.S. regulators will not allow it to market its painkiller Fentora for anyone other than cancer patients until the company implements enhancements to the drug’s risk management program.
Reuters Health Information
FDA Approves Extended-Release Levetiracetam as Adjunctive Therapy for Epilepsy
The new add-on treatment for partial-onset seizures is expected to be available in US pharmacies the end of September.
Medscape Medical News
Emerging Therapies, Including Bristol-Myers Squibb/Medarex’s Ipilimumab, Will Drive Growth In The Malignant Melanoma Drug Market
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the malignant melanoma drug market, driven by the launch of emerging agents, will experience robust annual 12 percent growth through 2012 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Ketogenic Diet May Be Helpful for Infantile Spasms
Children with epilepsy who were treated with a ketogenic diet versus the usual treatment of adrenocorticotropic hormone had good resolution of spasms and fewer adverse effects.
Medscape Medical News
Vegetable, Fruit Intake May Help Protect Men From Colorectal Cancer
A study shows that vegetable and fruit intake is inversely related to colorectal cancer risk in men but not in women; the association appears stronger for colon than for rectal cancer.
Medscape Medical News
Dermoscopy May Help Distinguish Melanoma Lacking Significant Pigment From Benign Lesions
Dermoscopy may help distinguish melanoma lacking significant pigment from benign lesions, though its diagnostic accuracy in these cases is inferior to that of more pigmented lesions.
Medscape Medical News
Social Network
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Aug | Oct » | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | |||||
Recent Entries
- Circassia Completes Patient Recruitment For Phase II Clinical Trial Of Toleromune(R) Allergy Treatment
- ImQuest Submits Investigational New Product Application To The Food And Drug Administration To Initiate HIV Therapeutic Clinical Trials With IQP-0410
- FDA Issues A Complete Response Letter For Lilly’s Olanzapine LAI For Treatment Of Schizophrenia In Adults
- Kaunitz on Women’s Health: A Safer Approach to Prescribing Menopausal Estrogen
- Sun Pharmaceutical extends tender offer for Taro
- Sun Pharmaceutical receives FDA approvals for 4 generics
- Codexis announces licensing agreement with Teva Pharmaceutical Industries
- GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
- Codexis, Teva in Licensing Agreement Final
- FDA Safety Changes: Norditropin, Rozerem, Zomig
Recent Comments
- Keine Kommentare vorhanden.
Translators
Categories
- Addictions
- Alcohol Abuse
- Complementary and Alternative Medicine
- Drug Approvals
- Drug Evaluation and Research
- Drug Shortages
- Drugs and Food Information
- Food and Nutrition Information
- Health Information
- Illegal Drugs
- Medical Devices
- Medical Devices and Radiological Health
- Pharmaceutical Industry News
- Pharmacist News
- Safety Information
- Uncategorized
Archives
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 1969
Pages
Blogroll
- Alcohol / Addiction / Illegal Drugs News From Medical News Today - Latest Alcohol / Addiction / Illegal Drugs News From Medical News Today.
- Alcohol and Alcoholism - current issue - Alcohol and Alcoholism - RSS feed of current issue
- CDRH Consumer News - Items added to the Center for Devices and Radiological Health’s Consumer website within the last month.
- Centre for Reviews and Dissemination (CRD) - CRD undertakes reviews of research about the effects of interventions used in health and social care.
- Complementary and Alternative Medicine Specialist Librar